Zobrazeno 1 - 10
of 212
pro vyhledávání: '"Alan R Schned"'
Autor:
Stella Koutros, Manolis Kogevinas, Melissa C. Friesen, Patricia A. Stewart, Dalsu Baris, Margaret R. Karagas, Molly Schwenn, Alison Johnson, G.M. Monawar Hosain, Consol Serra, Adonina Tardon, Alfredo Carrato, Reina Garcia-Closas, Lee E. Moore, Michael L. Nickerson, Stephen M. Hewitt, Petra Lenz, Alan R. Schned, Josep Lloreta, Yves Allory, Haoyu Zhang, Nilanjan Chatterjee, Montserrat Garcia-Closas, Nathaniel Rothman, Núria Malats, Debra T. Silverman
Publikováno v:
Environment International, Vol 135, Iss , Pp - (2020)
Background: The International Agency for Research on Cancer (IARC) classifies diesel engine exhaust as carcinogenic to humans based on sufficient evidence for lung cancer. IARC noted, however, an increased risk of bladder cancer (based on limited evi
Externí odkaz:
https://doaj.org/article/f2b72acb3c9d49f9abd84304e70ad58e
Autor:
Reno C. Leeming, Stella Koutros, Margaret R. Karagas, Dalsu Baris, Molly Schwenn, Alison Johnson, Michael S. Zens, Alan R. Schned, Nathaniel Rothman, Debra T. Silverman, Michael N. Passarelli
Publikováno v:
European Journal of Nutrition. 61:3905-3913
Autor:
Reno C. Leeming, Margaret R. Karagas, Diane Gilbert-Diamond, Jennifer A. Emond, Michael S. Zens, Alan R. Schned, John D. Seigne, Michael N. Passarelli
Publikováno v:
Nutr Cancer
Nutrition may impact bladder cancer survival. We examined the association between diet quality and overall and bladder cancer-specific survival. Bladder cancer cases from a population-based study reported pre-diagnosis diet. Diet quality was assessed
Identification of Let-7f-5p as a novel biomarker of recurrence in non-muscle invasive bladder cancer
Autor:
Margaret R. Karagas, Jason R. Pettus, John W Hinds, David A. Armstrong, Angeline S. Andrew, Carmen J. Marsit, John D. Seigne, Kevin Shee, Todd W. Miller, Alan R. Schned
Publikováno v:
Cancer Biomarkers. 29:101-110
BACKGROUND: Among patients diagnosed with non-muscle invasive bladder cancer (NMIBC), 30% to 70% experience recurrences within 6 to 12 years of diagnosis. The need to screen for these events every 3 to 6 months and ultimately annually by cystoscopy m
Autor:
Reno C, Leeming, Stella, Koutros, Margaret R, Karagas, Dalsu, Baris, Molly, Schwenn, Alison, Johnson, Michael S, Zens, Alan R, Schned, Nathaniel, Rothman, Debra T, Silverman, Michael N, Passarelli
Publikováno v:
European journal of nutrition. 61(8)
We examined the interaction between common genetic bladder cancer variants, diet quality, and bladder cancer risk in a population-based case-control study conducted in New England.At the time of enrollment, 806 bladder cancer cases and 974 controls p
Autor:
Margaret R. Karagas, Angeline S. Andrew, John D. Seigne, Jason R. Pettus, Carmen J. Marsit, Kevin Shee, Alan R. Schned, Todd W. Miller, David A. Armstrong
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:50% to 75% of patients with non-muscle invasive bladder cancer (NMIBC) experience recurrences within 6 to 12 years of diagnosis, and the cost of screening makes bladder c...
Autor:
Angeline S Andrew, Ting Hu, Jian Gu, Jiang Gui, Yuanqing Ye, Carmen J Marsit, Karl T Kelsey, Alan R Schned, Sam A Tanyos, Eben M Pendleton, Rebecca A Mason, Elaine V Morlock, Michael S Zens, Zhongze Li, Jason H Moore, Xifeng Wu, Margaret R Karagas
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e51301 (2012)
Bladder cancer is the 4(th) most common cancer among men in the U.S. We analyzed variant genotypes hypothesized to modify major biological processes involved in bladder carcinogenesis, including hormone regulation, apoptosis, DNA repair, immune surve
Externí odkaz:
https://doaj.org/article/2bd3b44368954f89932e96d6094d03e7
Autor:
Carmen J Marsit, E Andres Houseman, Brock C Christensen, Luc Gagne, Margaret R Wrensch, Heather H Nelson, Joseph Wiemels, Shichun Zheng, John K Wiencke, Angeline S Andrew, Alan R Schned, Margaret R Karagas, Karl T Kelsey
Publikováno v:
PLoS ONE, Vol 5, Iss 8, p e12334 (2010)
Approximately 500,000 individuals diagnosed with bladder cancer in the U.S. require routine cystoscopic follow-up to monitor for disease recurrences or progression, resulting in over $2 billion in annual expenditures. Identification of new diagnostic
Externí odkaz:
https://doaj.org/article/0bcd9da35e00445ea0be884fabe4e1ce
Publikováno v:
IEEE Transactions on Medical Imaging. 35:2513-2523
Prostate cancer (PCa) recurrences are often predicted by assessing the status of surgical margins (SM)– positive surgical margins (PSM) increase the chances of biochemical recurrence by 2-4 times which may lead to PCa recurrence. To this end, an el